Skip to main content
CUREXO, INC. logo

CUREXO, INC. — Investor Relations & Filings

Ticker · 060280 ISIN · KR7060280005 KO Manufacturing
Open in API
Filings indexed 197 across all filing types
Latest filing 2025-06-18 Report Publication Anno…
Country KR South Korea
Listing KO 060280

About CUREXO, INC.

https://www.curexo.com/eng/

CUREXO, INC. is a medical robotics company specializing in the development, manufacturing, and commercialization of advanced robotic systems for surgical and rehabilitation applications. The company's product portfolio includes the 'CUVIS-joint' for artificial knee replacement surgery, the 'CUVIS-spine' for guiding spinal procedures, and the 'MORNINGWALK' for gait rehabilitation therapy. CUREXO focuses on providing innovative medical solutions to address conditions such as degenerative arthritis and spinal disorders, aiming to improve surgical precision and patient recovery outcomes through its proprietary robotic technologies.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) meeting/presentation scheduled for June 19-20, 2025. It provides details such as the date, location, target audience, and purpose of the meeting. Since this is a short announcement notifying the public about the scheduling of an IR event rather than the presentation materials themselves, it falls under the category of a regulatory announcement regarding corporate events.
2025-06-18 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (912 characters) notifying the public of an upcoming Investor Relations (IR) event (Corporate Day). It provides the date, location, and purpose of the meeting, and mentions that IR materials will be distributed at the event or via the exchange's system. According to the 'Menu vs Meal' rule, since this is an announcement of an event/presentation rather than the presentation itself, and it serves as a regulatory notification of corporate activity, it is classified as a Report Publication Announcement (RPA).
2025-05-16 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Curexo Inc. (큐렉소주식회사) covering the period from 2025.01.01 to 2025.03.31. It contains detailed financial information, management discussion, and corporate governance details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Road Show). It provides details such as date, location, purpose, and contact information, and mentions that IR materials will be distributed at the event and posted on the exchange's system. Since it is an announcement of an event/presentation rather than the presentation itself, and it is under 5,000 characters, it falls under the category of a regulatory announcement regarding corporate activities.
2025-05-09 Korean
[기재정정]주식매수선택권부여에관한신고
Remuneration Information Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly marked as a '정정 신고' (Correction Report). It details changes to stock option grants, including the number of shares and the list of recipients, submitted to the Financial Services Commission/Korea Exchange. This falls under general regulatory announcements regarding corporate capital structure and equity-based compensation, which is best classified as a Regulatory Filing (RNS) as it does not fit into specific categories like DIRS (Director's Dealing) or SHA (Share Issue/Capital Change) which typically refer to direct market transactions or new share issuances.
2025-04-25 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly labeled as a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of shares and the list of recipients due to resignations. This type of filing is a standard regulatory disclosure regarding capital structure and employee compensation instruments, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2025-04-25 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.